About this trial
A repository of biospecimens and detailed phenotypic information collected longitudinally from adults with congenital heart disease and related conditions, with an aim to facilitate future research on biologic mechanisms of underlying disease, compensation and deterioration; biologic correlates of patient experience and functional status; associations between clinical characteristics and various biomarkers; and predictors of clinical outcomes.
Eligibility criteria
Qualifiers
Any person ≥ 16 years-old suspected of having or diagnosed with congenital heart disease (CHD), other cardiovascular disease (CVD), pulmonary hypertension, connective tissue disease, or genetic syndrome/diagnosis.
A family member or other person accompanying a patient to a clinical encounter; or,
A volunteer recruited via an advertisement; or,
Another person who volunteers to enroll in HIBR-ACHD.
Disqualifiers
Unable to provide informed consent/assent personally or via a legal guardian.
Considered unsafe to collect the biospecimen determined by either a clinical provider or an HIBR-ACHD investigator.
Overnight hospitalization for non-obstetric reason with discharge in the prior 30 days.
Trial design
Treatments tested in this trial
- Not listed